Adlai Nortye (ANL) to Release Earnings on Wednesday

Adlai Nortye (NASDAQ:ANL) is anticipated to issue its Q2 2025 results before the market opens on Wednesday, February 25th. Analysts expect Adlai Nortye to post earnings of ($0.1050) per share and revenue of $10.00 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q2 2025 earning report page for the latest details on the call scheduled for Friday, March 6, 2026 at 7:00 AM ET.

Adlai Nortye Price Performance

NASDAQ ANL opened at $9.98 on Tuesday. Adlai Nortye has a fifty-two week low of $0.88 and a fifty-two week high of $12.09. The business has a fifty day moving average of $4.62 and a 200-day moving average of $2.66.

Analysts Set New Price Targets

A number of research analysts have issued reports on ANL shares. Weiss Ratings restated a “sell (e+)” rating on shares of Adlai Nortye in a report on Wednesday, January 21st. HC Wainwright raised shares of Adlai Nortye from a “neutral” rating to a “buy” rating and set a $16.00 price objective for the company in a research report on Friday, February 13th. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Adlai Nortye has a consensus rating of “Hold” and a consensus target price of $16.00.

About Adlai Nortye

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.